NGM — NGM Biopharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for NGM Biopharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	345	295	366	271	144
Net Total Accounts Receivable
Net Total Receivables	5.21	6.43	4.95	7.58	0.058
Prepaid Expenses
Total Other Current Assets
Total Current Assets	355	308	379	289	156
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19.5	14.5	14.1	10.6	7.03
Other Long Term Assets
Total Assets	380	329	402	307	169
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	39.7	42.6	61.4	47.8	20.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	49.7	49	66.7	47.8	20.2
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	331	280	336	260	149
Total Liabilities & Shareholders' Equity	380	329	402	307	169
Total Common Shares Outstanding
Total Preferred Shares Outstanding